Back to Search Start Over

Severe Acute Respiratory Infection—Preparedness: Protocol for a Multicenter Prospective Cohort Study of Viral Respiratory Infections

Authors :
Radu Postelnicu, MD
Avantika Srivastava, MS
Pavan K. Bhatraju, MD, MSc
Mark M. Wurfelc, MD, PhD
George L. Anesi, MD, MSCE, MBE
Martin Gonzalez, MS
Adair Andrews, RN, MATD
Karen Lutrick, PhD
Vishakha K. Kumar, MD, MBA
Timothy M. Uyeki, MD, MPH
Perren J. Cobb, MD
Leopoldo N. Segal, MD
David Brett-Major, MD, MPH
Janice M. Liebler, MD
Christopher J. Kratochvil, MD
Vikramjit Mukherjee, MD
M. Jana Broadhurst, MD, PhD, DTM&H
Richard Lee, MD
David Wyles, MD
Jonathan E. Sevransky, MD, MHS
Laura Evans, MD, MSc
Douglas Landsittel, PhD
the Society of Critical Care Medicine Discovery Network Investigators
Source :
Critical Care Explorations, Vol 4, Iss 10, p e0773 (2022)
Publication Year :
2022
Publisher :
Wolters Kluwer, 2022.

Abstract

OBJECTIVES:. Respiratory virus infections cause significant morbidity and mortality ranging from mild uncomplicated acute respiratory illness to severe complications, such as acute respiratory distress syndrome, multiple organ failure, and death during epidemics and pandemics. We present a protocol to systematically study patients with severe acute respiratory infection (SARI), including severe acute respiratory syndrome coronavirus 2, due to respiratory viral pathogens to evaluate the natural history, prognostic biomarkers, and characteristics, including hospital stress, associated with clinical outcomes and severity. DESIGN:. Prospective cohort study. SETTING:. Multicenter cohort of patients admitted to an acute care ward or ICU from at least 15 hospitals representing diverse geographic regions across the United States. PATIENTS:. Patients with SARI caused by infection with respiratory viruses that can cause outbreaks, epidemics, and pandemics. INTERVENTIONS:. None. MEASUREMENTS AND MAIN RESULTS:. Measurements include patient demographics, signs, symptoms, and medications; microbiology, imaging, and associated tests; mechanical ventilation, hospital procedures, and other interventions; and clinical outcomes and hospital stress, with specimens collected on days 0, 3, and 7–14 after enrollment and at discharge. The primary outcome measure is the number of consecutive days alive and free of mechanical ventilation (VFD) in the first 30 days after hospital admission. Important secondary outcomes include organ failure-free days before acute kidney injury, shock, hepatic failure, disseminated intravascular coagulation, 28-day mortality, adaptive immunity, as well as immunologic and microbiologic outcomes. CONCLUSIONS:. SARI—Preparedness is a multicenter study under the collaboration of the Society of Critical Care Medicine Discovery, Resilience Intelligence Network, and National Emerging Special Pathogen Training and Education Center, which seeks to improve understanding of prognostic factors associated with worse outcomes and increased resource utilization. This can lead to interventions to mitigate the clinical impact of respiratory virus infections associated with SARI.

Details

Language :
English
ISSN :
26398028 and 00000000
Volume :
4
Issue :
10
Database :
Directory of Open Access Journals
Journal :
Critical Care Explorations
Publication Type :
Academic Journal
Accession number :
edsdoj.75495ee50470c9a3e0d5d7dc36345
Document Type :
article
Full Text :
https://doi.org/10.1097/CCE.0000000000000773